Erythropoietin as an antiapoptotic, tissue-protective cytokine
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Erythropoietin (EPO) increases the number of circulating erythrocytes primarily by preventing apoptosis of erythroid progenitors. In addition to this proerythroid action, results of recent studies show that systemically administered EPO is protective in vivo, in several animal models of neuronal injury. In vitro, EPO prevents neuronal apoptosis induced by a variety of stimuli. This review summarizes the neuroprotective actions of EPO and discusses the underlying mechanisms in terms of signal transduction pathways involved. The understanding of these mechanisms will help differentiate the neuroprotective actions of EPO from its role in the bone marrow.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2149]
Citations
Cites
Structural design and molecular evolution of a cytokine receptor superfamily.
Bazan, J. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.6934 · Cited by 2,069 · cited 1×
“cytokines of the IL-6 family (IL-6, leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF) and oncostatin M).(21,22)”
BackgroundNF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402
Self-citationVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A. V., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17977 · Cited by 1,282
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135 · cited 1×
“been suggested that, because HIF is often constitutively expressed in tumors, it may mediate the high constitutive expression of glycolytic enzymes that is the basis of the Warburg effect.(3,5)”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028 · cited 1×
“of human stroke by EPO used three daily doses substantially higher than the clinical norm and, in these patients, EPO was shown to be safe and did not raise the hemoglobin concentration.(80) Thus, this might represent a valuable therapeutic approach to acute CNS injury, such as brain and spinal cord trauma.”
Self-citationErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019 · cited 3×
“Using a model of ischemia with reperfusion, it was shown that neurons within the penumbra would undergo apoptosis unless exposed to EPO within 3 h of injury.(39) In addition to this antiapoptotic effect, EPO administration is also associated with a marked decrease in proinflammatory cytokines within the hemisphere und…”
BackgroundMethodInfluentialSelf-citationOosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Cited by
Brines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.-W., Smart, J., Su-Rick, C.-J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406491101 · Cited by 656
Self-citationTraumatic Brain Injury: Current Treatment Strategies and Future Endeavors
Galgano, M., Toshkezi, G., Qiu, X., Russell, T., Chin, L., & Zhao, L.-R. (2017) · Cell Transplantation · doi:10.1177/0963689717714102 · Cited by 582
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“[1968] Ghezzi, P.”
Emerging biological roles for erythropoietin in the nervous system
Brines, M., & Cerami, A. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1687 · Cited by 523
Self-citationVollmar, B., & Menger, M. D. (2009) · Physiological Reviews · doi:10.1152/physrev.00027.2008 · Cited by 500
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain
Russo, V. C., Gluckman, P. D., Feldman, E. L., & Werther, G. A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0024 · Cited by 492
Modulation of immune response by head injury
Morganti-Kossmann, M. C., Satgunaseelan, L., Bye, N., & Kossmann, T. (2007) · Injury · doi:10.1016/j.injury.2007.10.005 · Cited by 412
Holditch, S. J., Brown, C. N., Lombardi, A. M., Nguyen, K. N., & Edelstein, C. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123011 · Cited by 377
Mechanisms of testicular torsion and potential protective agents
Karaguzel, E., Kadihasanoglu, M., & Kutlu, O. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.135 · Cited by 266
Theus, M. H., Wei, L., Cui, L., Francis, K., Hu, X., Keogh, C., & Yu, S. P. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.020 · Cited by 248
“…its receptor are expressed in the nervous system and are upregulated after ischemic/hypoxic insults, exerting neuroprotection in cell cultures and in animal models of nervous system disorders (Marti et al., 1996; Bernaudin et al., 1999; Ghezzi and Brines, 2004; Wei et al., 2006; Li et al., 2007).”
Yatsiv, I., Grigoriadis, N., Simeonidou, C., Stahel, P. F., Schmidt, O. I., Alexandrovich, A. G., Tsenter, J., & Shohami, E. (2005) · The FASEB Journal · doi:10.1096/fj.05-3907fje · Cited by 241
Zhang, J., Wu, Y., Jin, Y., Ji, F., Sinclair, S. H., Luo, Y., Xu, G., Lu, L., Dai, W., Yanoff, M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0721 · Cited by 226
Dissection of intercellular communication using the transcriptome-based framework ICELLNET
Noël, F., Massenet-Regad, L., Carmi-Levy, I., Cappuccio, A., Grandclaudon, M., Trichot, C., Kieffer, Y., Mechta-Grigoriou, F., & Soumelis, V. (2021) · Nature Communications · doi:10.1038/s41467-021-21244-x · Cited by 209
Sun, Y., Calvert, J. W., & Zhang, J. H. (2005) · Stroke · doi:10.1161/01.str.0000173406.04891.8c · Cited by 205
Nonclassic Endogenous Novel Regulators of Angiogenesis
Ribatti, D., Conconi, M. T., & Nussdorfer, G. G. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.3 · Cited by 178
“Evidence has accumulated that EPO also exerts a marked proangiogenic effect during embryonic and adult life, as well as enhances tumor growth by promoting angiogenesis and decreasing apoptosis (Ghezzi and Brines, 2004; Jelkmann, 2004; Koury, 2005; Rossert and Eckardt, 2005; Hardee et al., 2006).”
BackgroundViviani, B., Bartesaghi, S., Corsini, E., Villa, P., Ghezzi, P., Garau, A., Galli, C. L., & Marinovich, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03033.x · Cited by 163
Self-citationAn adverse intrauterine environment: implications for injury and altered development of the brain
Rees, S., Harding, R., & Walker, D. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.08.020 · Cited by 160
“Erythropoetin, an anti-apoptotic and tissue protective cytokine, has also been shown to be effective in rodent models of brain damage (Ghezi and Brines, 2004) but its effectiveness in large animal models is still being determined (Rees et al., 2007).”
BackgroundSinclair, S. H., & Schwartz, S. S. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00843 · Cited by 170
Wang, Y., Zhang, Z. G., Rhodes, K., Renzi, M., Zhang, R. L., Kapke, A., Lu, M., Pool, C., Heavner, G., & Chopp, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707285 · Cited by 136
“Delayed treatment with rhEPO or CEPO reduces apoptosis and microglial activation Previous studies have reported that acute treatment with rhEPO prevents neuronal apoptosis and reduces activation of inflammatory cells within the CNS (Siren et al., 2001; Ghezzi and Brines, 2004).”
BackgroundHigh-altitude adaptation in humans: from genomics to integrative physiology
Azad, P., Stobdan, T., Zhou, D., Hartley, I., Akbari, A., Bafna, V., & Haddad, G. G. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1584-7 · Cited by 118
“the maturation of red blood cells from erythroid progenitors and mediates erythropoiesis but also mediates non-erythroid processes such as angiogenesis, and immune regulation [77].”
Gorio, A., Madaschi, L., Di Stefano, B., Carelli, S., Di Giulio, A. M., De Biasi, S., Coleman, T., Cerami, A., & Brines, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508479102 · Cited by 127
Self-citationErythropoietin and Cancer: The Unintended Consequences of Anemia Correction
Debeljak, N., Solár, P., & Sytkowski, A. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00563 · Cited by 133
George, J., Goldstein, E., Abashidze, A., Wexler, D., Hamed, S., Shmilovich, H., DEUTSCH, V., Miller, H. I., Keren, G., & Roth, A. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.022 · Cited by 126
Pathophysiology of anemia and erythrocytosis
Hodges, V. M., Rainey, S., Lappin, T. R. J., & Maxwell, A. P. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.06.006 · Cited by 133
McVicar, C., Hamilton, R. W., Colhoun, L. M., Gardiner, T. A., Brines, M. L., Cerami, A., & Stitt, A. W. (2011) · Diabetes · doi:10.2337/db11-0026 · Cited by 119
“EPO is highly expressed in many organs (2), and its upregulation can prevent apoptosis and associated inflammation (3).”
BackgroundSelf-citationAristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches
Anger, E. E., Yu, F., & Li, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031157 · Cited by 124
Ishii, T., Asai, T., Oyama, D., Fukuta, T., Yasuda, N., Shimizu, K., Minamino, T., & Oku, N. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.004 · Cited by 120
Erythropoietin as a neuroprotective agent in traumatic brain injury
Mammis, A., McIntosh, T. K., & Maniker, A. H. (2008) · Surgical Neurology · doi:10.1016/j.surneu.2008.02.040 · Cited by 121
“Erythropoietin is a member of the cytokine type I superfamily [12].”
BackgroundSavino, C., Pedotti, R., Baggi, F., Ubiali, F., Gallo, B. M., Nava, S., Bigini, P., Barbera, S., Fumagalli, E. R., Mennini, T., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.10.016 · Cited by 115
“In addition to its hemopoietic effects, erythropoietin (EPO) possesses neuroprotective and neurotrophic proper- ties (Brines and Cerami, 2005; Ghezzi and Brines, 2004; Jelkmann and Wagner, 2004; Juul, 2004).”
BackgroundSelf-citationNadam, J., Navarro, F. P., Sanchez, P. E., Moulin, C., Georges, B., Laglaine, A., Péquignot, J.-M., Morales, A., Ryvlin, P., & Bezin, L. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.009 · Cited by 110
“…Blood– brain barrier; Neocortex; Spinal cord; Neuroprotection Introduction Erythropoietin (Epo) was originally described for its role in hematopoiesis, which consists of increasing red blood cells (Jelkmann, 1992) by protecting erythroid progenitors against apoptosis (Ghezzi and Brines, 2004).”
BackgroundThe wobbler mouse, an ALS animal model
Moser, J. M., Bigini, P., & Schmitt-John, T. (2013) · Molecular Genetics and Genomics · doi:10.1007/s00438-013-0741-0 · Cited by 98
“In recent years, it has widely been demonstrated that the neuroprotective effect of erythropoietin and its derivates is related to both, trophic-antiapoptotic activity and antiinflammatory action (Ghezzi and Brines 2004).”
BackgroundChan, W. M., & McFadden, G. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085442 · Cited by 119
“In some animal experiments, rhEPO was shown to have antiapoptotic effects, induce angiogenesis, and promote tumor growth (81, 82).”
BackgroundSong, X., Wei, W., Cheng, W., Zhu, H., Wang, W., Dong, H., & Li, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.939532 · Cited by 108
Salehi, M., Naseri‐Nosar, M., Ebrahimi‐Barough, S., Nourani, M., Khojasteh, A., Hamidieh, A. A., Amani, A., Farzamfar, S., & Ai, J. (2017) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.33952 · Cited by 104
Recombinant Human Erythropoietin Prevents the Death of Mice during Cerebral Malaria
Kaiser, K., Texier, A., Ferrandiz, J., Buguet, A., Meiller, A., Latour, C., Peyron, F., Cespuglio, R., & Picot, S. (2006) · The Journal of Infectious Diseases · doi:10.1086/500844 · Cited by 103
“Systematically administered EPO crosses the bloodbrain barrier via the abundant expression of EPO receptors (EPORs) in brain capillaries and acts as an antiapoptotic and cytoprotective cytokine [7].”
Topical erythropoietin promotes wound repair in diabetic rats
Hamed, S., Ullmann, Y., Masoud, M., Hellou, E., Khamaysi, Z., & Teot, L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.219 · Cited by 102
“Erythropoietin (EPO) is a glycoprotein hormone that regulates the red blood cell mass by stimulating the proliferation and differentiation of precursor cells, and inhibiting apoptosis in erythroid cells in the bone marrow (Jelkmann, 1994; Ghezzi and Brines, 2004; Brines and Cerami, 2006).”
Bond, W. S., & Rex, T. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00523 · Cited by 105
“Comprehensive reviews on the anti-apoptotic effect of EPO in the CNS are available (4, 8, 9).”
BackgroundProlyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection
Harten, S. K., Ashcroft, M., & Maxwell, P. H. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2870 · Cited by 99
“In vitro EPO added to neuronal cultures protects from both hypoxic and glutamic injury (172) and numerous groups have reported that EPO is neuroprotective in rodent models of cerebral ischemic damage, traumatic brain injury, and spinal cord injury (26, 68, 74, 155, 162, 196, 205, 230, 270).”
Novel pharmacotherapies to abrogate postinfarction ventricular remodeling
Dorn, G. W. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.12 · Cited by 112
Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection
Gunnarson, E., Song, Y., Kowalewski, J. M., Brismar, H., Brines, M. L., Cerami, A., Andersson, U., Zelenina, M., & Aperia, A. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812708106 · Cited by 107
Self-citationThe therapeutic potential of insulin-like growth factor-1 in central nervous system disorders
Costales, J., & Kolevzon, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.01.001 · Cited by 93
“One such cytokine is erythropoietin (EPO), which has overlapping functions with IGF-1 pathways and function in vivo to protect neurons from ischemic damage (Buemi et al., 2005; Fischer, Wiesnet, Marti, Renz, & Schaper, 2004; Ghezzi & Brines, 2004).”
BackgroundMoon, C., Krawczyk, M., Paik, D., Coleman, T. R., Brines, M. L., Juhaszova, M., Sollott, S. J., Lakatta, E. G., & Talan, M. I. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.094854 · Cited by 97
“…of EPO effects, many possible antiapoptotic signaling pathways have been reported: Jak-2/STAT, PI3K, protein kinase C, p38, p42/44 mitogen-activated protein kinase activation, KATP, and Akt (Brines et al., 2000; Calvillo et al., 2003; Parsa et al., 2003; Ghezzi and Brines, 2004; Shi et al., 2004).”
BackgroundSelf-citationAlternative Erythropoietin Receptors in the Nervous System
Ostrowski, D., & Heinrich, R. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020024 · Cited by 100
Mengozzi, M., Cervellini, I., Villa, P., Erbayraktar, Z., Gökmen, N., Yilmaz, O., Erbayraktar, S., Manohasandra, M., Van Hummelen, P., Vandenabeele, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200554109 · Cited by 94
Self-citationStier, A., Reichert, S., Criscuolo, F., & Bize, P. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.09.001 · Cited by 98
“Experimental manipulations of RBC number and lifespan are feasible through injection of the erythropoietin hormone (Ghezzi and Brines, 2004), but also by using chemical treatments lysing RBCs (Fronstin et al., 2015).”
MethodGrimm, C., Hermann, D. M., Bogdanova, A. Y., Hotop, S., Kılıç, Ü., Wenzel, A., Kılıç, E., & Gassmann, M. (2005) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2005.03.004 · Cited by 92
Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
Soliz, J., Gasser, E. M. S., Arias‐Reyes, C., Aliaga‐Raduán, F., Poma-Machicao, L., Zubieta-Calleja, G. R., Furuya, W. I., Trevizan‐Baú, P., Dhingra, R. R., & Dutschmann, M. (2020) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103476 · Cited by 96
“Accordingly, EPO exerts a neuroprotective function in ischemic stroke and traumatic brain injury models in rodents, monkeys and humans (Brines et al., 2004; Gassmann et al., 2003; Ghezzi and Brines, 2004; Gorio et al., 2002) and can prevent cardio-respiratory dysfunction following exposure to chronic intermittent hypo…”
Li, F., Zhong Chong, Z., & Maiese, K. (2006) · Current Neurovascular Research · doi:10.2174/156720206778018758 · Cited by 82
“…less prominence than those involving Akt1, one of three family members of the protein kinase B family that is highly expressed in the brain (Chong, et al., 2005b) and serves as a central regulator for the proliferative and protective attributes of EPO (Ghezzi and Brines, 2004,Maiese, et al., 2004).”
BackgroundMolecular and cellular immune mediators of neuroprotection
Turrin, N. P., & Rivest, S. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:221 · Cited by 85
Effects of erythropoietin in skin wound healing are dose related
Sorg, H., Krueger, C., Schulz, T., Menger, M. D., Schmitz, F., & Vollmar, B. (2009) · The FASEB Journal · doi:10.1096/fj.08-109991 · Cited by 87
Asialoerythropoietin Prevents Contrast-Induced Nephropathy
Yokomaku, Y., Sugimoto, T., Kume, S., Araki, S., Isshiki, K., Chin‒Kanasaki, M., Sakaguchi, M., Nitta, N., Haneda, M., Koya, D., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040481 · Cited by 88
Erythropoietin: A Novel Neuroprotective Cytokine
Bartesaghi, S., Marinovich, M., Corsini, E., Galli, C. L., & Viviani, B. (2005) · NeuroToxicology · doi:10.1016/j.neuro.2005.01.016 · Cited by 84
Luo, B., Wang, J., Liu, Z., Shen, Z., Shi, R., Liu, Y., Liu, Y., Jiang, M., Wu, Y., & Zhang, Z. (2016) · Nature Communications · doi:10.1038/ncomms12177 · Cited by 85
Intense Exercise Promotes Adult Hippocampal Neurogenesis But Not Spatial Discrimination
So, J. H., Huang, C., Ge, M., Cai, G., Zhang, L., Lu, Y., & Mu, Y. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00013 · Cited by 75
“Similar to VEGF, EPO is produced under hypoxic conditions, which can protect neurons from oxidative stress, ischemia, and stroke (Ghezzi and Brines, 2004).”
Yamaguchi, M., Jadhav, V. R., Obenaus, A., Colohan, A. R. T., & Zhang, J. H. (2007) · Neurosurgery · doi:10.1227/01.neu.0000303203.07866.18 · Cited by 80
“Erythropoietin, although neuroprotective in many cerebrovascular disorders (13), increased brain edema after SBI by a possible vascular endothelial growth factor-mediated mechanism (40).”
BackgroundErythropoietin improves myocardial performance in doxorubicin-induced cardiomyopathy
Hamed, S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl044 · Cited by 78
Therapeutic effects of erythropoietin in murine models of endotoxin shock*
Aoshiba, K., Onizawa, S., Tsuji, T., & Nagai, A. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819b8371 · Cited by 74
“Interestingly, a previous study showed that the inhibitory effect of erythropoietin on iNOS requires activation of the phospholipase C 1 and protein kinase C pathway (17), which is not reported as a signaling pathway leading to inhibition of apoptosis (20, 22), suggesting that erythropoietin influences different cell…”
BackgroundOkazaki, T., Ebihara, S., Asada, M., Yamanda, S., Niu, K., & Arai, H. (2008) · Neoplasia · doi:10.1593/neo.08140 · Cited by 73
Hamed, S., Bennett, C. L., Demiot, C., Ullmann, Y., Téot, L., & Desmoulière, A. (2013) · Wound Repair and Regeneration · doi:10.1111/wrr.12135 · Cited by 80
Higgins, S. J., Kain, K. C., & Liles, W. C. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.96 · Cited by 77
Human hair follicles are an extrarenal source and a nonhematopoietic target of erythropoietin
Bodó, E., Kromminga, A., Funk, W., Laugsch, M., Duske, U., Jelkmann, W., & Paus, R. (2007) · The FASEB Journal · doi:10.1096/fj.07-8628com · Cited by 71
Erythropoietin in neonatal brain protection: The past, the present and the future
Kumral, A., Tüzün, F., Öner, M. G., Genç, Ş., Duman, N., & Özkan, H. (2010) · Brain and Development · doi:10.1016/j.braindev.2010.10.014 · Cited by 70
Najafi, M., Tavakol, S., Zarrabi, A., & Ashrafizadeh, M. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1773864 · Cited by 70
“The studies show that EPO can protect cells against damages due to its anti-apoptotic and antioxidant activities (Eid and Brines 2002, Ghezzi and Brines 2004, Luo et al. 2013, Rjiba-Touati et al. 2013, Ercan et al. 2014).”
BackgroundErythropoietin: ready for prime-time cardioprotection
Riksen, N. P., Hausenloy, D. J., & Yellon, D. M. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.02.002 · Cited by 80
Biomaterialien bei Cochlea-Implantaten
Stöver, T., & Lenarz, T. (2009) · Laryngo-Rhino-Otologie · doi:10.1055/s-0028-1119552 · Cited by 70
Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo
Logar, C. M., Brinkkoetter, P. T., Krofft, R. D., Pippin, J. W., & Shankland, S. J. (2007) · Kidney International · doi:10.1038/sj.ki.5002362 · Cited by 70
“First, we performed the 3-[4,5] Podocyte membrane Podocyte cytosol Fibroblast cytosol Fibroblast membrane”
MethodLe, K. M., Klemm, K., Abshagen, K., Eipel, C., Menger, M. D., & Vollmar, B. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061056 · Cited by 67
“Unsere Hypothese ist, dass pleiotrope Substanzen, wie Erythropoietin, welches neben der hämatopoetischen Wirkung als zytoprotektives, mitogenes und anti-apoptotisches Zytokin für Herz, Hirn und Niere beschrieben ist [3], zur Therapie des septischen Leberschadens ideal geeignet sind.”
BackgroundAnderson, J., Sandhir, R., Hamilton, E. S., & Berman, N. E. J. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0765 · Cited by 62
“EPO is an endogenous glycoprotein hormone that has been shown to have neuroprotective properties in focal ischemia, global ischemia, neonatal hypoxia-ischemia, subarachanoid hemorrhage, and trauma (Ghezzi and Brines, 2004).”
Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue
Rotter, R., Menshykova, M., Winkler, T., Matziolis, G., Stratos, I., Schoen, M., Bittorf, T., Mittlmeier, T., & Vollmar, B. (2008) · Journal of Orthopaedic Research® · doi:10.1002/jor.20692 · Cited by 61
Imamura, R., Moriyama, T., Isaka, Y., Namba, Y., Ichimaru, N., Takahara, S., & Okuyama, Ä. (2007) · Transplantation · doi:10.1097/01.tp.0000264200.38926.70 · Cited by 60
Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin
Zakharova, E. T., Av, S., Павличенко, Н. Н., Kostevich, V. A., Abdurasulova, I. N., Владимирович, Ч. А., Voynova, I. V., Elizarova, A. Y., Kolmakov, N. N., Bass, M. G., et al. (2018) · BioMetals · doi:10.1007/s10534-018-0111-9 · Cited by 62
Age-related changes in adaptation to severe anemia in childhood in developing countries
O’Donnell, A., Premawardhena, A., Arambepola, M., Allen, S. J., Peto, T., Fisher, C., Rees, D. C., Olivieri, N. F., & Weatherall, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703424104 · Cited by 60
Kashkouli, M. B., Yousefi, S., Nojomi, M., Sanjari, M. S., Pakdel, F., Entezari, M., Razavi, M. E., Razeghinejad, R., Esmaeli, M., Shafiee, M., et al. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3816-5 · Cited by 58
“Therefore, it has presented anti-ischemic, anti-inflammatory, anti-oxidative, and anti-apoptosis effects [8], all of which play role in presumed pathophysiology of TON.”
BackgroundErythropoietin activates nitric oxide synthase in murine erythrocytes
Mihov, D., Vogel, J., Gassmann, M., & Bogdanova, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00543.2008 · Cited by 55
Fantacci, M., Bianciardi, P., Caretti, A., Coleman, T. R., Cerami, A., Brines, M. L., & Samaja, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608814103 · Cited by 54
Self-citationPlant recombinant erythropoietin attenuates inflammatory kidney cell injury
Conley, A. J., Mohib, K., Jevnikar, A. M., & Brandle, J. E. (2008) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2008.00389.x · Cited by 56
Cyclophilin A in Cardiovascular Homeostasis and Diseases
Satoh, K. (2014) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.235.1 · Cited by 51
“Instead, Epo has been shown to exert direct protective effects on ECs (Ghezzi and Brines 2004; Noguchi et al. 2008).”
BackgroundCan erythropoietin be used to prevent brain damage in cerebral malaria?
Casals‐Pascual, C., Idro, R., Picot, S., Roberts, D. J., & Newton, C. R. J. C. (2008) · Trends in Parasitology · doi:10.1016/j.pt.2008.10.002 · Cited by 55
Artesunate–erythropoietin combination for murine cerebral malaria treatment
Bienvenu, A., Ferrandiz, J., Kaiser, K., Latour, C., & Picot, S. (2008) · Acta Tropica · doi:10.1016/j.actatropica.2008.02.001 · Cited by 53
“To obtain the appearance of exogenous Epo in the cerebrospinal fluid and the neuroprotective effect, Epo doses higher than those used for anemia treatment are needed (Brines and Cerami, 2006; Ghezzi and Brines, 2004).”
BackgroundKaneko, N., Kako, E., & Sawamoto, K. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00235 · Cited by 53
“A number of studies have revealed beneficial effects of EPO administration in various animal models for CNS diseases (Ghezzi and Brines, 2004; Maiese et al., 2004; van der Kooij et al., 2008) and in patients with ischemic stroke, schizophrenia, and multiple sclerosis (Siren et al., 2009).”
BackgroundMethodInfluentialGrmec, Š., Strnad, M., Kupnik, D., Sinkovič, A., & Gazmuri, R. J. (2009) · Resuscitation · doi:10.1016/j.resuscitation.2009.03.010 · Cited by 50
Chemosensitization by erythropoietin through inhibition of the NF-κB rescue pathway
Carvalho, G., Lefaucheur, C., Cherbonnier, C., Métivier, D., Chapel, A., Pallardy, M. J., Bourgeade, M., Charpentier, B., Hirsch, F., & Kroemer, G. (2004) · Oncogene · doi:10.1038/sj.onc.1208205 · Cited by 59
Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain
Sifringer, M., Brait, D., Weichelt, U., Zimmerman, G., Endesfelder, S., Brehmer, F., von Haefen, C., Friedman, A., Soreq, H., Bendix, I., et al. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.08.010 · Cited by 55
Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali
Picot, S., Bienvenu, A., Konaté, S., Sissoko, S., Barry, A., Diarra, E., Bamba, K., DJIMDÉ, A. A., & Doumbo, O. K. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-169 · Cited by 50
Hypoxic Preconditioning and Erythropoietin Protect Retinal Neurons from Degeneration
Grimm, C., Wenzel, A., Acar, N., Keller, S. S., Seeliger, M. W., & Gassmann, M. (2006) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-34817-9_11 · Cited by 48
TNF-alpha-induced apoptosis is prevented by erythropoietin treatment on SH-SY5Y cells
Pregi, N., Wenker, S. D., Vittori, D. C., Leirós, C. P., & Nesse, A. B. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.005 · Cited by 48
Chattopadhyay, M., Walter, C., Mata, M. M., & Fink, D. J. (2008) · Brain · doi:10.1093/brain/awp014 · Cited by 47
“…of several downstream signalling pathways, including Ras-mitogenactivated protein-kinases (MAPKs), phosphatidylinositol-3-kinase (PI3K), and signal transducers and activators of transcription-5 (STAT-5) (Siren et al., 2001a; Ruscher et al., 2002; Chong et al., 2003; Ghezzi and Brines, 2004).”
BackgroundTaşçılar, Ö., Cakmak, G. K., Tekin, İ. Ö., Emre, A., Uçan, B. H., Bahadır, B., Açıkgöz, Ş., İrkörücü, O., Karakaya, K., Balbaloĝlu, H., et al. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i46.6172 · Cited by 47
Yamada, M., Burke, C. J., Colditz, P. B., Johnson, D. W., & Gobe, G. C. (2011) · The Journal of Pathology · doi:10.1002/path.2862 · Cited by 46
Models and treatments for traumatic optic neuropathy and demyelinating optic neuritis
Bastakis, G. G., Ktena, N., Karagogeos, D., & Savvaki, M. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22710 · Cited by 49
“Moreover, through NF‐kB activation, it results in reduction of proapoptotic factors (BAD) and increase of anti‐apoptotic factors (Bcl‐xL, Bax) (Chong, Kang, & Maiese, 2003; Ghezzi & Brines, 2004; Hernandez et al., 2017).”
BackgroundErythropoietin improves brain mitochondrial function in rats after traumatic brain injury
Xiong, Y., Chopp, M., & Lee, C.-P. (2008) · Neurological Research · doi:10.1179/174313208x353703 · Cited by 45
Cruz, Y. R., Mengana, T. Y., Cernada, A. M., Martinez, N. S., González‐Quevedo, A., Testé, I. S., & Rodríguez, J. C. G. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.215 · Cited by 50
“To assess the mechanisms through which nasal Neuro-EPO achieves its neuroprotective effect is beyond the scope of this work, but we speculate that they are probably related toh the same mechanisms described for rHu-EPO or its derivatives CEPO or sialo EPO in different models of stroke: antiapoptotic[42,43,44,45], anti…”
BackgroundCellular mechanisms of emerging applications of mesenchymal stem cells.
Mok, P. L., Leong, C. F., & Cheong, S. (2013) · PubMed · Cited by 48
Luo, B., Wang, Z., Zhang, Z., Shen, Z., & Zhang, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.005 · Cited by 42
Erythropoietin ameliorates podocyte injury in advanced diabetic nephropathy in thedb/dbmouse
Loeffler, I., Rüster, C., Franke, S., Liebisch, M., & Wolf, G. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00643.2012 · Cited by 45
Reisi, P., Arabpoor, Z., Hamidi, G. A., Rashidi, B., Shabrang, M., Alaei, H., Sharifi, M., Salami, M., & Dolatabadi, H. R. D. (2012) · Advanced Biomedical Research · doi:10.4103/2277-9175.100157 · Cited by 41
Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use
Perrone, S., Lembo, C., Gironi, F., Petrolini, C., Catalucci, T., Corbo, G., Buonocore, G., Gitto, E., & Esposito, S. (2022) · Antioxidants · doi:10.3390/antiox11040652 · Cited by 43
“angiogenesis [74,86,87], oligodendrogenesis, neuronal progenitors migration in the ischemic areas”
BackgroundEffect of erythropoietin on oxygen-induced brain injury in the newborn rat
Yiş, U., Kurul, S. H., Kumral, A., Tuğyan, K., Cilaker, S., Yılmaz, O., Genç, Ş., & Genç, K. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.10.060 · Cited by 40
Mpekoulis, G., Frakolaki, E., Τaka, S., Ioannidis, A., Vassiliou, A. G., Kalliampakou, K. I., Patas, K., Karakasiliοtis, I., Aidinis, V., Chatzipanagiotou, S., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253458 · Cited by 39
“Another reason for SARS-CoV2 to target EPO could be the anti-apoptotic properties [42] of the encoded protein, as the virus induces cell death in VeroE6, shown in S8 Fig in S2 File [35] and also in previous studies [43, 44].”
ResultSorg, H., Harder, Y., Krueger, C., Reimers, K., & Vogt, P. M. (2012) · Medicinal Research Reviews · doi:10.1002/med.21259 · Cited by 42
Metadata
- Authors
- Ghezzi, P., & Brines, M.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- Oswego Community Hospital (US)
- Corresponding author
- Ghezzi, P
- Venue
- Cell Death & Differentiation
- Published
- 2004-07
- Volume
- 11
- Issue
- S1
- Pages
- S37-S44
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2121188367
- Cited by
- 327
- References
- 94
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 14 · 2019: 11 · 2018: 13 · 2017: 12 · 2016: 9 · 2015: 7 · 2014: 18 · 2013: 15 · 2012: 18
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutional Research information system (University of Urbino) (submittedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Keywords
- erythropoietin, neuroprotection, neuronal apoptosis, signaling pathways, erythroid progenitor cells, tissue protection, bone marrow erythropoiesis
- MeSH terms
- Animals, Anti-Inflammatory Agents, DNA-Binding Proteins, Epithelial Cells, Erythropoietin, Hematopoiesis, Humans, Inflammation, Kidney Tubules, Models, Biological, Neurons, Nuclear Proteins, Transcription Factors, Signal Transduction, Cytokines, Myocardial Ischemia, Apoptosis, Neuroprotective Agents, Cytoprotection, Trauma, Nervous System, Endothelial Cells, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.